SS

Sue Susan MacLeman

Rhythm Biosciences Limited | Non-Executive Director
Mr MacLeman has more than 30 years experience as a pharmaceutical, biotechnology and medical technology executive having held senior roles in corporate, medical, commercial and business development at Schering Plough Corporation (now Merck), Amgen, Bristol Myers Squibb and Mesoblast. Sue has also served as CEO and a Board member of several ASX, AIM and NASDAQ listed companies in the Healthtech sector. Sue is currently the Chair of the Medical Technologies and Pharmaceuticals Growth Centre (MTPConnect). Sue is a Non Executive Director of Planet Innovation Holdings Ltd, ATSE and OMICO (Australian Genomic Cancer Medicines Ltd). Sue is also appointed to several academic and government advisory boards. Sue brings a unique set of experiences in technology commercialisation, strategic planning, capital markets and fund raising, M&A and alliance management.

Company and Role

Company
Title
Tenure
Since
RHY
Rhythm Biosciences Limited
  • Non-Executive Director
1yrs, 3mthJan 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RHY
Rhythm Biosciences Limited
10/10/230N/A200,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RHY
Rhythm Biosciences Limited
10/10/23
Issued
200,000$0.305$61,000Issue of options